Sage Mountain Advisors’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$132K Sell
2022
Q3
$139K Sell
2022
Q2
$774K Sell
2022
Q1
$794K Sell
2021
Q4
$894K Sell
2021
Q3
$911K Sell
2021
Q2
$939K Hold
2021
Q1
$922K Buy